

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin-mediated cell contraction (GO:0070252) | 9.71111127 |
| 2 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 9.26779027 |
| 3 | skeletal muscle adaptation (GO:0043501) | 9.15212980 |
| 4 | skeletal muscle fiber development (GO:0048741) | 8.95323047 |
| 5 | myotube cell development (GO:0014904) | 7.56828951 |
| 6 | actin filament-based movement (GO:0030048) | 7.33747731 |
| 7 | plasma membrane repair (GO:0001778) | 7.14213241 |
| 8 | striated muscle atrophy (GO:0014891) | 6.56256030 |
| 9 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.26930154 |
| 10 | sarcomere organization (GO:0045214) | 6.14642102 |
| 11 | skeletal muscle tissue regeneration (GO:0043403) | 6.10896341 |
| 12 | striated muscle contraction (GO:0006941) | 6.09745018 |
| 13 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.97482968 |
| 14 | response to inactivity (GO:0014854) | 5.65212706 |
| 15 | muscle atrophy (GO:0014889) | 5.59459209 |
| 16 | response to muscle activity (GO:0014850) | 5.56914874 |
| 17 | purine nucleotide salvage (GO:0032261) | 5.43089203 |
| 18 | glycogen catabolic process (GO:0005980) | 5.42713274 |
| 19 | myofibril assembly (GO:0030239) | 5.41786671 |
| 20 | muscle fiber development (GO:0048747) | 5.28612712 |
| 21 | creatine metabolic process (GO:0006600) | 5.24004172 |
| 22 | striated muscle adaptation (GO:0014888) | 5.15009394 |
| 23 | muscle contraction (GO:0006936) | 5.12374201 |
| 24 | glucan catabolic process (GO:0009251) | 5.05207582 |
| 25 | carnitine shuttle (GO:0006853) | 4.96123968 |
| 26 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.94793924 |
| 27 | muscle organ morphogenesis (GO:0048644) | 4.93550132 |
| 28 | IMP metabolic process (GO:0046040) | 4.89288977 |
| 29 | cellular polysaccharide catabolic process (GO:0044247) | 4.65837156 |
| 30 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.63722018 |
| 31 | muscle cell fate commitment (GO:0042693) | 4.60333747 |
| 32 | muscle system process (GO:0003012) | 4.56584292 |
| 33 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.51303917 |
| 34 | positive regulation of myotube differentiation (GO:0010831) | 4.48238537 |
| 35 | regulation of cell communication by electrical coupling (GO:0010649) | 4.48071923 |
| 36 | myotube differentiation (GO:0014902) | 4.43231269 |
| 37 | polysaccharide catabolic process (GO:0000272) | 4.41451619 |
| 38 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.32212552 |
| 39 | actomyosin structure organization (GO:0031032) | 4.31367524 |
| 40 | glucan biosynthetic process (GO:0009250) | 4.26657033 |
| 41 | glycogen biosynthetic process (GO:0005978) | 4.26657033 |
| 42 | neuronal action potential propagation (GO:0019227) | 4.22194509 |
| 43 | striated muscle cell development (GO:0055002) | 4.14690031 |
| 44 | muscle adaptation (GO:0043500) | 4.09640575 |
| 45 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.09547610 |
| 46 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 4.04374174 |
| 47 | muscle cell cellular homeostasis (GO:0046716) | 4.02888815 |
| 48 | cytidine metabolic process (GO:0046087) | 4.02340790 |
| 49 | cytidine catabolic process (GO:0006216) | 4.02340790 |
| 50 | cytidine deamination (GO:0009972) | 4.02340790 |
| 51 | fatty acid transmembrane transport (GO:1902001) | 4.00741487 |
| 52 | cardiac muscle hypertrophy (GO:0003300) | 4.00312572 |
| 53 | regulation of actin filament-based movement (GO:1903115) | 3.95991622 |
| 54 | neuromuscular synaptic transmission (GO:0007274) | 3.94441521 |
| 55 | myoblast fusion (GO:0007520) | 3.91575555 |
| 56 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.83317226 |
| 57 | striated muscle hypertrophy (GO:0014897) | 3.81114250 |
| 58 | DNA damage induced protein phosphorylation (GO:0006975) | 3.76287615 |
| 59 | skeletal muscle tissue development (GO:0007519) | 3.76124268 |
| 60 | fructose metabolic process (GO:0006000) | 3.75670896 |
| 61 | * muscle organ development (GO:0007517) | 3.72623750 |
| 62 | gluconeogenesis (GO:0006094) | 3.71802620 |
| 63 | * muscle structure development (GO:0061061) | 3.70029214 |
| 64 | glycogen metabolic process (GO:0005977) | 3.68868928 |
| 65 | muscle tissue morphogenesis (GO:0060415) | 3.66858417 |
| 66 | adult heart development (GO:0007512) | 3.66846580 |
| 67 | NADH metabolic process (GO:0006734) | 3.66573565 |
| 68 | negative regulation of skeletal muscle tissue development (GO:0048642) | 3.65141799 |
| 69 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.65106910 |
| 70 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.65011633 |
| 71 | glucan metabolic process (GO:0044042) | 3.60587635 |
| 72 | cellular glucan metabolic process (GO:0006073) | 3.60587635 |
| 73 | response to activity (GO:0014823) | 3.58181380 |
| 74 | muscle cell development (GO:0055001) | 3.57815716 |
| 75 | IMP biosynthetic process (GO:0006188) | 3.57478326 |
| 76 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.57095884 |
| 77 | carnitine transmembrane transport (GO:1902603) | 3.54203287 |
| 78 | regulation of striated muscle contraction (GO:0006942) | 3.45706013 |
| 79 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.45261739 |
| 80 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.44531095 |
| 81 | syncytium formation (GO:0006949) | 3.41814817 |
| 82 | positive regulation of myoblast differentiation (GO:0045663) | 3.41144718 |
| 83 | negative regulation of muscle hypertrophy (GO:0014741) | 3.40305402 |
| 84 | cranial nerve morphogenesis (GO:0021602) | 3.39014012 |
| 85 | cytoplasmic microtubule organization (GO:0031122) | 3.38503785 |
| 86 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.33114582 |
| 87 | hexose biosynthetic process (GO:0019319) | 3.32487901 |
| 88 | muscle hypertrophy (GO:0014896) | 3.31943379 |
| 89 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.31452531 |
| 90 | cardiac muscle cell development (GO:0055013) | 3.31440760 |
| 91 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.30841801 |
| 92 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 3.29714559 |
| 93 | AMP metabolic process (GO:0046033) | 3.29653234 |
| 94 | neuromuscular junction development (GO:0007528) | 3.28647904 |
| 95 | respiratory system process (GO:0003016) | 3.28612542 |
| 96 | 2-oxoglutarate metabolic process (GO:0006103) | 3.28280966 |
| 97 | regulation of cofactor metabolic process (GO:0051193) | 3.22623067 |
| 98 | regulation of coenzyme metabolic process (GO:0051196) | 3.22623067 |
| 99 | striated muscle tissue development (GO:0014706) | 3.21682555 |
| 100 | amino-acid betaine transport (GO:0015838) | 3.21062809 |
| 101 | carnitine transport (GO:0015879) | 3.21062809 |
| 102 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.19975067 |
| 103 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.19975067 |
| 104 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.16452909 |
| 105 | cardiac muscle adaptation (GO:0014887) | 3.16362257 |
| 106 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.16362257 |
| 107 | muscle hypertrophy in response to stress (GO:0003299) | 3.16362257 |
| 108 | regulation of sarcomere organization (GO:0060297) | 3.16012405 |
| 109 | regulation of membrane repolarization (GO:0060306) | 3.15515761 |
| 110 | cardiac muscle contraction (GO:0060048) | 3.13861933 |
| 111 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.11095653 |
| 112 | regulation of myotube differentiation (GO:0010830) | 3.09725451 |
| 113 | ubiquinone biosynthetic process (GO:0006744) | 3.09559522 |
| 114 | cardiac cell development (GO:0055006) | 3.08999400 |
| 115 | cardiac myofibril assembly (GO:0055003) | 3.06374015 |
| 116 | skeletal muscle cell differentiation (GO:0035914) | 3.04361806 |
| 117 | positive regulation of cation channel activity (GO:2001259) | 3.02753212 |
| 118 | regulation of myoblast differentiation (GO:0045661) | 3.02723328 |
| 119 | oxidative phosphorylation (GO:0006119) | 3.02128075 |
| 120 | negative regulation of cell size (GO:0045792) | 2.95280875 |
| 121 | regulation of relaxation of muscle (GO:1901077) | 2.93986802 |
| 122 | cellular carbohydrate catabolic process (GO:0044275) | 2.93908606 |
| 123 | cellular response to dexamethasone stimulus (GO:0071549) | 2.83228957 |
| 124 | heart contraction (GO:0060047) | 2.80268686 |
| 125 | heart process (GO:0003015) | 2.80268686 |
| 126 | intracellular lipid transport (GO:0032365) | 2.80199019 |
| 127 | regulation of sulfur metabolic process (GO:0042762) | 2.78909782 |
| 128 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.74641870 |
| 129 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.71432026 |
| 130 | actin-myosin filament sliding (GO:0033275) | 11.5981417 |
| 131 | muscle filament sliding (GO:0030049) | 11.5981417 |
| 132 | skeletal muscle contraction (GO:0003009) | 10.9165404 |
| 133 | regulation of skeletal muscle contraction (GO:0014819) | 10.8200704 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.36954827 |
| 2 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 4.21552047 |
| 3 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.18038296 |
| 4 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 3.05542026 |
| 5 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.05255108 |
| 6 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.83382580 |
| 7 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.64214733 |
| 8 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.62658552 |
| 9 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.55849042 |
| 10 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.55346077 |
| 11 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 2.39725017 |
| 12 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.38894689 |
| 13 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 2.37781866 |
| 14 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.33887141 |
| 15 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.33887141 |
| 16 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.31951579 |
| 17 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.29893821 |
| 18 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.27568281 |
| 19 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.17104007 |
| 20 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.17104007 |
| 21 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.15093217 |
| 22 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.14800817 |
| 23 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.13976164 |
| 24 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.12283873 |
| 25 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.05974564 |
| 26 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.00536767 |
| 27 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.87532270 |
| 28 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.86330633 |
| 29 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.86219880 |
| 30 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.83489716 |
| 31 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.81276655 |
| 32 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.78237862 |
| 33 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.77393632 |
| 34 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.76733032 |
| 35 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.76628371 |
| 36 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.73930494 |
| 37 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.70815527 |
| 38 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.69963807 |
| 39 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.69205615 |
| 40 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.67901208 |
| 41 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.66528245 |
| 42 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.64808560 |
| 43 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.62508150 |
| 44 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.62307861 |
| 45 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.60932820 |
| 46 | ATF3_27146783_Chip-Seq_COLON_Human | 1.60605099 |
| 47 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.54494664 |
| 48 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.54163401 |
| 49 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.49242138 |
| 50 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.49035792 |
| 51 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.47692116 |
| 52 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.46129976 |
| 53 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.45795815 |
| 54 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.45654951 |
| 55 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.44692845 |
| 56 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.43207263 |
| 57 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.40404595 |
| 58 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.38775189 |
| 59 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.38145922 |
| 60 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.37701338 |
| 61 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.36537043 |
| 62 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.36198120 |
| 63 | * STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.35261126 |
| 64 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.34903691 |
| 65 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.33591392 |
| 66 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.32432148 |
| 67 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.29977577 |
| 68 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.29468839 |
| 69 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.28655780 |
| 70 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.27244807 |
| 71 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.26827706 |
| 72 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.26589780 |
| 73 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.26527394 |
| 74 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23945266 |
| 75 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.23114911 |
| 76 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.22135779 |
| 77 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.21893129 |
| 78 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.21150860 |
| 79 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.20888581 |
| 80 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.20449564 |
| 81 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.20122284 |
| 82 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.18636094 |
| 83 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.18174982 |
| 84 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.17808978 |
| 85 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.16404563 |
| 86 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.15614607 |
| 87 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.14884488 |
| 88 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.14187556 |
| 89 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.13961403 |
| 90 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.12936744 |
| 91 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.11676053 |
| 92 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.10821828 |
| 93 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.10676255 |
| 94 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.09310934 |
| 95 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.09294288 |
| 96 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09195652 |
| 97 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09094032 |
| 98 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08472770 |
| 99 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07949160 |
| 100 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.07805178 |
| 101 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.07727099 |
| 102 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.06710879 |
| 103 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.06140329 |
| 104 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.05744288 |
| 105 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.05411582 |
| 106 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.04908969 |
| 107 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.04741123 |
| 108 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.04485097 |
| 109 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.04197868 |
| 110 | P68_20966046_ChIP-Seq_HELA_Human | 1.03313700 |
| 111 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.03016554 |
| 112 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.00424227 |
| 113 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.00399071 |
| 114 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.00142304 |
| 115 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.00028841 |
| 116 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.99485301 |
| 117 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.99308777 |
| 118 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.99269755 |
| 119 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.97897887 |
| 120 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.97780019 |
| 121 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.97081505 |
| 122 | CJUN_26792858_Chip-Seq_BT549_Human | 0.95995415 |
| 123 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.95909312 |
| 124 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.93975175 |
| 125 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.93743161 |
| 126 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.92932400 |
| 127 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.92718058 |
| 128 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.92439142 |
| 129 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.91897559 |
| 130 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.91834828 |
| 131 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.91507650 |
| 132 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.91489417 |
| 133 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.91471370 |
| 134 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.91441739 |
| 135 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 0.90993392 |
| 136 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.90139589 |
| 137 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.89084355 |
| 138 | * FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.87853536 |
| 139 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.87154551 |
| 140 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.86882504 |
| 141 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.86635636 |
| 142 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.86087570 |
| 143 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.84315364 |
| 144 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 0.83689067 |
| 145 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.83421641 |
| 146 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.83313870 |
| 147 | * MNX1_26342078_ChIP-Seq_MIN6-4N_Mouse | 0.83290175 |
| 148 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.82994827 |
| 149 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.82162544 |
| 150 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.82028367 |
| 151 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.81843368 |
| 152 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.81843368 |
| 153 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.80602435 |
| 154 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.79781839 |
| 155 | TBL1_22424771_ChIP-Seq_293T_Human | 0.78851774 |
| 156 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.78650392 |
| 157 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.77056987 |
| 158 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.76992436 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 7.85611533 |
| 2 | MP0003646_muscle_fatigue | 6.96785275 |
| 3 | MP0000749_muscle_degeneration | 5.90128228 |
| 4 | MP0000751_myopathy | 5.33710547 |
| 5 | MP0002822_catalepsy | 4.79737393 |
| 6 | MP0000747_muscle_weakness | 4.28718646 |
| 7 | MP0002106_abnormal_muscle_physiology | 4.26572239 |
| 8 | MP0000750_abnormal_muscle_regeneration | 3.77768059 |
| 9 | * MP0000759_abnormal_skeletal_muscle | 3.69481792 |
| 10 | MP0005369_muscle_phenotype | 3.51517277 |
| 11 | MP0004036_abnormal_muscle_relaxation | 3.47522297 |
| 12 | MP0002269_muscular_atrophy | 3.44275579 |
| 13 | MP0004087_abnormal_muscle_fiber | 3.32421065 |
| 14 | MP0005620_abnormal_muscle_contractility | 2.82043753 |
| 15 | * MP0000733_abnormal_muscle_development | 2.78826632 |
| 16 | MP0004233_abnormal_muscle_weight | 2.75903042 |
| 17 | MP0002837_dystrophic_cardiac_calcinosis | 2.71368826 |
| 18 | MP0004130_abnormal_muscle_cell | 2.54568539 |
| 19 | MP0004185_abnormal_adipocyte_glucose | 2.19324429 |
| 20 | MP0002332_abnormal_exercise_endurance | 2.11590958 |
| 21 | MP0004270_analgesia | 2.01260534 |
| 22 | MP0002108_abnormal_muscle_morphology | 1.96026489 |
| 23 | MP0005451_abnormal_body_composition | 1.65037330 |
| 24 | MP0005330_cardiomyopathy | 1.47266830 |
| 25 | MP0002971_abnormal_brown_adipose | 1.44475794 |
| 26 | MP0006036_abnormal_mitochondrial_physio | 1.39496146 |
| 27 | MP0003221_abnormal_cardiomyocyte_apopto | 1.34437354 |
| 28 | MP0005666_abnormal_adipose_tissue | 1.33148124 |
| 29 | MP0009250_abnormal_appendicular_skeleto | 1.27369266 |
| 30 | MP0004084_abnormal_cardiac_muscle | 1.24606336 |
| 31 | MP0003950_abnormal_plasma_membrane | 1.21997393 |
| 32 | MP0001299_abnormal_eye_distance/ | 1.18136581 |
| 33 | MP0004215_abnormal_myocardial_fiber | 1.13022564 |
| 34 | MP0010630_abnormal_cardiac_muscle | 1.05387636 |
| 35 | MP0004484_altered_response_of | 1.02786813 |
| 36 | MP0002972_abnormal_cardiac_muscle | 0.98036520 |
| 37 | MP0003705_abnormal_hypodermis_morpholog | 0.97721406 |
| 38 | MP0005375_adipose_tissue_phenotype | 0.94863159 |
| 39 | MP0005266_abnormal_metabolism | 0.91375350 |
| 40 | MP0001849_ear_inflammation | 0.89083621 |
| 41 | MP0002735_abnormal_chemical_nociception | 0.85728698 |
| 42 | MP0010030_abnormal_orbit_morphology | 0.83255833 |
| 43 | MP0005670_abnormal_white_adipose | 0.82932936 |
| 44 | MP0002249_abnormal_larynx_morphology | 0.82137317 |
| 45 | MP0002653_abnormal_ependyma_morphology | 0.81372031 |
| 46 | MP0002114_abnormal_axial_skeleton | 0.78335932 |
| 47 | MP0005257_abnormal_intraocular_pressure | 0.74018848 |
| 48 | MP0003755_abnormal_palate_morphology | 0.73488344 |
| 49 | MP0001346_abnormal_lacrimal_gland | 0.72257003 |
| 50 | MP0000049_abnormal_middle_ear | 0.71720490 |
| 51 | MP0001661_extended_life_span | 0.70552132 |
| 52 | MP0002234_abnormal_pharynx_morphology | 0.68420048 |
| 53 | MP0000003_abnormal_adipose_tissue | 0.67778802 |
| 54 | MP0005423_abnormal_somatic_nervous | 0.67630870 |
| 55 | MP0003137_abnormal_impulse_conducting | 0.67389309 |
| 56 | MP0004134_abnormal_chest_morphology | 0.66454869 |
| 57 | MP0003879_abnormal_hair_cell | 0.65906262 |
| 58 | MP0003385_abnormal_body_wall | 0.65509298 |
| 59 | * MP0000955_abnormal_spinal_cord | 0.65432322 |
| 60 | MP0000013_abnormal_adipose_tissue | 0.65202908 |
| 61 | MP0003656_abnormal_erythrocyte_physiolo | 0.64842580 |
| 62 | MP0005623_abnormal_meninges_morphology | 0.64636967 |
| 63 | MP0006035_abnormal_mitochondrial_morpho | 0.64153396 |
| 64 | MP0000762_abnormal_tongue_morphology | 0.64123041 |
| 65 | MP0004924_abnormal_behavior | 0.64043243 |
| 66 | MP0005386_behavior/neurological_phenoty | 0.64043243 |
| 67 | MP0000534_abnormal_ureter_morphology | 0.63323702 |
| 68 | MP0001544_abnormal_cardiovascular_syste | 0.63160324 |
| 69 | MP0005385_cardiovascular_system_phenoty | 0.63160324 |
| 70 | MP0002932_abnormal_joint_morphology | 0.62766202 |
| 71 | MP0009672_abnormal_birth_weight | 0.62293504 |
| 72 | MP0002184_abnormal_innervation | 0.61923292 |
| 73 | MP0003718_maternal_effect | 0.61693043 |
| 74 | MP0000678_abnormal_parathyroid_gland | 0.61203632 |
| 75 | MP0001529_abnormal_vocalization | 0.58172881 |
| 76 | MP0002733_abnormal_thermal_nociception | 0.55771109 |
| 77 | MP0002877_abnormal_melanocyte_morpholog | 0.54429124 |
| 78 | * MP0000266_abnormal_heart_morphology | 0.53731091 |
| 79 | MP0008961_abnormal_basal_metabolism | 0.52415757 |
| 80 | MP0004085_abnormal_heartbeat | 0.51835960 |
| 81 | MP0003937_abnormal_limbs/digits/tail_de | 0.51668113 |
| 82 | MP0005167_abnormal_blood-brain_barrier | 0.50662212 |
| 83 | MP0008775_abnormal_heart_ventricle | 0.50236937 |
| 84 | MP0000579_abnormal_nail_morphology | 0.49847200 |
| 85 | MP0000372_irregular_coat_pigmentation | 0.49347825 |
| 86 | MP0005187_abnormal_penis_morphology | 0.49210649 |
| 87 | MP0002734_abnormal_mechanical_nocicepti | 0.48734766 |
| 88 | MP0002127_abnormal_cardiovascular_syste | 0.48648797 |
| 89 | MP0001943_abnormal_respiration | 0.48120950 |
| 90 | MP0002067_abnormal_sensory_capabilities | 0.47892231 |
| 91 | MP0005076_abnormal_cell_differentiation | 0.47531220 |
| 92 | MP0001440_abnormal_grooming_behavior | 0.47515473 |
| 93 | MP0003635_abnormal_synaptic_transmissio | 0.46202519 |
| 94 | MP0005452_abnormal_adipose_tissue | 0.45438102 |
| 95 | MP0009780_abnormal_chondrocyte_physiolo | 0.45080423 |
| 96 | MP0003283_abnormal_digestive_organ | 0.42562655 |
| 97 | MP0004858_abnormal_nervous_system | 0.41207796 |
| 98 | MP0004147_increased_porphyrin_level | 0.40376136 |
| 99 | MP0003828_pulmonary_edema | 0.39683683 |
| 100 | MP0006276_abnormal_autonomic_nervous | 0.39238944 |
| 101 | * MP0002081_perinatal_lethality | 0.38643406 |
| 102 | MP0002078_abnormal_glucose_homeostasis | 0.38052939 |
| 103 | MP0003567_abnormal_fetal_cardiomyocyte | 0.36630592 |
| 104 | MP0006138_congestive_heart_failure | 0.36380107 |
| 105 | MP0003806_abnormal_nucleotide_metabolis | 0.35996709 |
| 106 | * MP0002752_abnormal_somatic_nervous | 0.35955072 |
| 107 | MP0004859_abnormal_synaptic_plasticity | 0.35879368 |
| 108 | MP0008569_lethality_at_weaning | 0.35532185 |
| 109 | MP0002084_abnormal_developmental_patter | 0.35008859 |
| 110 | MP0002116_abnormal_craniofacial_bone | 0.34903016 |
| 111 | MP0002272_abnormal_nervous_system | 0.34706509 |
| 112 | MP0003948_abnormal_gas_homeostasis | 0.34550655 |
| 113 | MP0003699_abnormal_female_reproductive | 0.34113249 |
| 114 | MP0004197_abnormal_fetal_growth/weight/ | 0.32759575 |
| 115 | MP0000428_abnormal_craniofacial_morphol | 0.32542450 |
| 116 | MP0002163_abnormal_gland_morphology | 0.32141625 |
| 117 | MP0004510_myositis | 0.32003012 |
| 118 | MP0002089_abnormal_postnatal_growth/wei | 0.31875516 |
| 119 | MP0003111_abnormal_nucleus_morphology | 0.31510941 |
| 120 | MP0004142_abnormal_muscle_tone | 0.31442832 |
| 121 | MP0003077_abnormal_cell_cycle | 0.31432994 |
| 122 | MP0009115_abnormal_fat_cell | 0.31366632 |
| 123 | MP0005334_abnormal_fat_pad | 0.30733761 |
| 124 | * MP0002085_abnormal_embryonic_tissue | 0.30635729 |
| 125 | MP0001697_abnormal_embryo_size | 0.30011527 |
| 126 | * MP0002109_abnormal_limb_morphology | 0.28711840 |
| 127 | MP0004043_abnormal_pH_regulation | 0.28340324 |
| 128 | MP0002177_abnormal_outer_ear | 0.27473536 |
| 129 | * MP0001730_embryonic_growth_arrest | 0.26907716 |
| 130 | MP0008770_decreased_survivor_rate | 0.26854184 |
| 131 | MP0000350_abnormal_cell_proliferation | 0.25524914 |
| 132 | MP0000432_abnormal_head_morphology | 0.24600051 |
| 133 | * MP0002066_abnormal_motor_capabilities/c | 0.23784374 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 9.83691602 |
| 2 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 9.51055604 |
| 3 | Nemaline bodies (HP:0003798) | 8.73234255 |
| 4 | Exercise-induced myalgia (HP:0003738) | 7.90929350 |
| 5 | Distal arthrogryposis (HP:0005684) | 7.24490719 |
| 6 | Exercise-induced muscle cramps (HP:0003710) | 7.13286385 |
| 7 | Type 1 muscle fiber predominance (HP:0003803) | 6.95060807 |
| 8 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.61246623 |
| 9 | Myopathic facies (HP:0002058) | 6.53018140 |
| 10 | Round ear (HP:0100830) | 6.28508962 |
| 11 | Ulnar deviation of the wrist (HP:0003049) | 6.18615458 |
| 12 | Calf muscle hypertrophy (HP:0008981) | 5.87968951 |
| 13 | Calcaneovalgus deformity (HP:0001848) | 5.75504652 |
| 14 | Difficulty running (HP:0009046) | 5.68150929 |
| 15 | Muscle fiber splitting (HP:0003555) | 5.48791947 |
| 16 | Deformed tarsal bones (HP:0008119) | 5.25570545 |
| 17 | Absent phalangeal crease (HP:0006109) | 5.09202314 |
| 18 | Hyporeflexia of lower limbs (HP:0002600) | 4.37344587 |
| 19 | Muscle stiffness (HP:0003552) | 4.35118672 |
| 20 | EMG: myopathic abnormalities (HP:0003458) | 4.32793519 |
| 21 | Myoglobinuria (HP:0002913) | 4.29062509 |
| 22 | Malignant hyperthermia (HP:0002047) | 4.26410772 |
| 23 | Abnormal finger flexion creases (HP:0006143) | 4.25753778 |
| 24 | Increased connective tissue (HP:0009025) | 4.11519165 |
| 25 | Abnormality of the calf musculature (HP:0001430) | 4.07595936 |
| 26 | Myotonia (HP:0002486) | 3.98898612 |
| 27 | Difficulty climbing stairs (HP:0003551) | 3.93037853 |
| 28 | Rhabdomyolysis (HP:0003201) | 3.74125352 |
| 29 | Pelvic girdle muscle weakness (HP:0003749) | 3.65114772 |
| 30 | Shoulder girdle muscle weakness (HP:0003547) | 3.64125036 |
| 31 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.49200136 |
| 32 | Abnormality of the musculature of the pelvis (HP:0001469) | 3.46872998 |
| 33 | Abnormality of the hip-girdle musculature (HP:0001445) | 3.46872998 |
| 34 | Abnormality of the calcaneus (HP:0008364) | 3.42278910 |
| 35 | Neck muscle weakness (HP:0000467) | 3.39938077 |
| 36 | Fatigable weakness (HP:0003473) | 3.36062884 |
| 37 | Abnormality of the neuromuscular junction (HP:0003398) | 3.36062884 |
| 38 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.29559937 |
| 39 | Subaortic stenosis (HP:0001682) | 3.29559937 |
| 40 | Fetal akinesia sequence (HP:0001989) | 3.25917387 |
| 41 | Increased variability in muscle fiber diameter (HP:0003557) | 3.09523099 |
| 42 | Areflexia of lower limbs (HP:0002522) | 3.08929462 |
| 43 | Rimmed vacuoles (HP:0003805) | 3.08208625 |
| 44 | Frequent falls (HP:0002359) | 2.83186292 |
| 45 | Gowers sign (HP:0003391) | 2.57522780 |
| 46 | Weak cry (HP:0001612) | 2.56105713 |
| 47 | Bundle branch block (HP:0011710) | 2.56006474 |
| 48 | EMG: neuropathic changes (HP:0003445) | 2.55997274 |
| 49 | Hyperkalemia (HP:0002153) | 2.55157582 |
| 50 | Nonprogressive disorder (HP:0003680) | 2.45819916 |
| 51 | Type 2 muscle fiber atrophy (HP:0003554) | 2.40716560 |
| 52 | Bulbar palsy (HP:0001283) | 2.39605772 |
| 53 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.38850554 |
| 54 | Hypoplastic ischia (HP:0003175) | 2.38057445 |
| 55 | Proximal amyotrophy (HP:0007126) | 2.35321042 |
| 56 | Asymmetric septal hypertrophy (HP:0001670) | 2.33846347 |
| 57 | Limb-girdle muscle weakness (HP:0003325) | 2.33145427 |
| 58 | Slender build (HP:0001533) | 2.31502006 |
| 59 | Metatarsus adductus (HP:0001840) | 2.29110275 |
| 60 | Muscular dystrophy (HP:0003560) | 2.28480448 |
| 61 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.25210462 |
| 62 | Muscle fiber atrophy (HP:0100295) | 2.23470777 |
| 63 | Sudden death (HP:0001699) | 2.19213741 |
| 64 | Generalized muscle weakness (HP:0003324) | 2.19049807 |
| 65 | Ulnar deviation of finger (HP:0009465) | 2.18838814 |
| 66 | Distal lower limb amyotrophy (HP:0008944) | 2.18808099 |
| 67 | Dilated cardiomyopathy (HP:0001644) | 2.18358205 |
| 68 | Hip contracture (HP:0003273) | 2.17335946 |
| 69 | Distal lower limb muscle weakness (HP:0009053) | 2.16064407 |
| 70 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.07646436 |
| 71 | Acute lymphatic leukemia (HP:0006721) | 2.07545046 |
| 72 | Scapular winging (HP:0003691) | 2.06657827 |
| 73 | Paralysis (HP:0003470) | 2.04287525 |
| 74 | Ventricular tachycardia (HP:0004756) | 2.02534883 |
| 75 | Abnormality of the ischium (HP:0003174) | 2.02384822 |
| 76 | Abnormality of the foot musculature (HP:0001436) | 1.96717091 |
| 77 | Increased density of long bones (HP:0006392) | 1.95840084 |
| 78 | Facial diplegia (HP:0001349) | 1.93931522 |
| 79 | Achilles tendon contracture (HP:0001771) | 1.92734481 |
| 80 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.89431077 |
| 81 | Limb-girdle muscle atrophy (HP:0003797) | 1.86300571 |
| 82 | Spinal rigidity (HP:0003306) | 1.86191957 |
| 83 | Exercise intolerance (HP:0003546) | 1.85041629 |
| 84 | Progressive muscle weakness (HP:0003323) | 1.84190474 |
| 85 | Waddling gait (HP:0002515) | 1.83697694 |
| 86 | Lipoatrophy (HP:0100578) | 1.82618565 |
| 87 | Foot dorsiflexor weakness (HP:0009027) | 1.82266675 |
| 88 | Short palpebral fissure (HP:0012745) | 1.81215074 |
| 89 | Tarsal synostosis (HP:0008368) | 1.78568102 |
| 90 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.74629306 |
| 91 | Heart block (HP:0012722) | 1.72428539 |
| 92 | Abnormality of the Achilles tendon (HP:0005109) | 1.71429658 |
| 93 | Popliteal pterygium (HP:0009756) | 1.68054748 |
| 94 | Easy fatigability (HP:0003388) | 1.66334586 |
| 95 | Fibular aplasia (HP:0002990) | 1.66025477 |
| 96 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.62991189 |
| 97 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.62073406 |
| 98 | Synostosis involving bones of the feet (HP:0009140) | 1.62073406 |
| 99 | Long clavicles (HP:0000890) | 1.61954597 |
| 100 | Webbed neck (HP:0000465) | 1.60217473 |
| 101 | Abnormal atrioventricular conduction (HP:0005150) | 1.59199785 |
| 102 | Lower limb amyotrophy (HP:0007210) | 1.57945063 |
| 103 | Congenital hip dislocation (HP:0001374) | 1.56747888 |
| 104 | Breech presentation (HP:0001623) | 1.56483812 |
| 105 | Abnormality of placental membranes (HP:0011409) | 1.56149943 |
| 106 | Amniotic constriction ring (HP:0009775) | 1.56149943 |
| 107 | Steppage gait (HP:0003376) | 1.55707394 |
| 108 | Wrist flexion contracture (HP:0001239) | 1.54979639 |
| 109 | Increased intramyocellular lipid droplets (HP:0012240) | 1.54235799 |
| 110 | Adducted thumb (HP:0001181) | 1.53835510 |
| 111 | Ragged-red muscle fibers (HP:0003200) | 1.50135525 |
| 112 | Rocker bottom foot (HP:0001838) | 1.49782760 |
| 113 | Limited hip movement (HP:0008800) | 1.49011304 |
| 114 | Ventricular arrhythmia (HP:0004308) | 1.46198251 |
| 115 | Increased muscle lipid content (HP:0009058) | 1.44253508 |
| 116 | Hypoplastic heart (HP:0001961) | 1.40349033 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 7.27225509 |
| 2 | TTN | 5.18367190 |
| 3 | PHKG2 | 4.64555786 |
| 4 | PHKG1 | 4.64555786 |
| 5 | NME1 | 3.43656110 |
| 6 | LATS1 | 3.25335961 |
| 7 | MUSK | 2.97577223 |
| 8 | PIK3CG | 2.93569057 |
| 9 | LATS2 | 2.76181681 |
| 10 | MOS | 2.69621606 |
| 11 | TRIB3 | 2.39229435 |
| 12 | PINK1 | 2.28810130 |
| 13 | NEK1 | 2.24158438 |
| 14 | MAP2K3 | 2.10169789 |
| 15 | MARK1 | 2.09704245 |
| 16 | DMPK | 1.93088678 |
| 17 | STK38L | 1.90805389 |
| 18 | MAP3K6 | 1.76374205 |
| 19 | MAP2K4 | 1.68224330 |
| 20 | MAP3K7 | 1.62016504 |
| 21 | TAOK1 | 1.61053965 |
| 22 | KSR2 | 1.37025790 |
| 23 | CDK8 | 1.32931204 |
| 24 | PDK3 | 1.23643778 |
| 25 | PDK4 | 1.23643778 |
| 26 | MAPK12 | 1.21535264 |
| 27 | MAP2K7 | 1.08126103 |
| 28 | PRKAA1 | 1.04405643 |
| 29 | PIK3CA | 1.02657475 |
| 30 | DYRK1B | 1.01711723 |
| 31 | SIK2 | 1.01056736 |
| 32 | PAK6 | 0.98302350 |
| 33 | ERBB4 | 0.96669834 |
| 34 | STK3 | 0.95003932 |
| 35 | VRK2 | 0.88333770 |
| 36 | CCNB1 | 0.86684608 |
| 37 | PRKAA2 | 0.84620670 |
| 38 | ICK | 0.82947194 |
| 39 | STK38 | 0.82572583 |
| 40 | MAP2K6 | 0.81940210 |
| 41 | MAP3K9 | 0.78466242 |
| 42 | STK24 | 0.73407870 |
| 43 | EEF2K | 0.72356344 |
| 44 | MAPKAPK3 | 0.70512403 |
| 45 | AKT2 | 0.69564642 |
| 46 | MAPK11 | 0.68820349 |
| 47 | PDK2 | 0.68638535 |
| 48 | MAP3K13 | 0.68543149 |
| 49 | BCKDK | 0.66489381 |
| 50 | RAF1 | 0.66138228 |
| 51 | KSR1 | 0.64297086 |
| 52 | ILK | 0.64150700 |
| 53 | PRKD3 | 0.63210074 |
| 54 | NEK9 | 0.61276883 |
| 55 | MAP3K4 | 0.61151177 |
| 56 | CAMK4 | 0.60578293 |
| 57 | TAOK3 | 0.60409013 |
| 58 | SMG1 | 0.59946522 |
| 59 | MAP3K5 | 0.59863150 |
| 60 | EPHA4 | 0.58203262 |
| 61 | LIMK1 | 0.56592755 |
| 62 | PKN1 | 0.55234685 |
| 63 | CDC7 | 0.54019318 |
| 64 | DYRK2 | 0.53918910 |
| 65 | PKN2 | 0.53542334 |
| 66 | PLK4 | 0.51986600 |
| 67 | MAP2K1 | 0.48592198 |
| 68 | TAF1 | 0.47685539 |
| 69 | ABL2 | 0.45595328 |
| 70 | MAPK4 | 0.45459169 |
| 71 | TTK | 0.45287944 |
| 72 | TYRO3 | 0.44518504 |
| 73 | MARK3 | 0.44342761 |
| 74 | CAMK1 | 0.44275456 |
| 75 | CAMK2G | 0.44052612 |
| 76 | GRK1 | 0.42871570 |
| 77 | TAOK2 | 0.41319794 |
| 78 | NEK2 | 0.39575122 |
| 79 | CDK9 | 0.39223294 |
| 80 | CAMK2A | 0.37626507 |
| 81 | CHEK2 | 0.35720527 |
| 82 | MELK | 0.35236652 |
| 83 | MAP3K11 | 0.34660984 |
| 84 | MAPK7 | 0.34490550 |
| 85 | TRPM7 | 0.32876270 |
| 86 | ERBB3 | 0.32605483 |
| 87 | PRKACA | 0.31680273 |
| 88 | CAMK2B | 0.31656288 |
| 89 | MAP3K3 | 0.31368250 |
| 90 | EPHB1 | 0.31219899 |
| 91 | DYRK3 | 0.31106715 |
| 92 | BRAF | 0.30407384 |
| 93 | MAPK10 | 0.30081547 |
| 94 | BMPR2 | 0.29885323 |
| 95 | MAPK13 | 0.29648655 |
| 96 | CAMK2D | 0.28491575 |
| 97 | SGK3 | 0.28068808 |
| 98 | ADRBK2 | 0.27599038 |
| 99 | CDK12 | 0.27300472 |
| 100 | RET | 0.26896337 |
| 101 | RPS6KA3 | 0.25905711 |
| 102 | SGK1 | 0.24978168 |
| 103 | MTOR | 0.24596277 |
| 104 | MAP3K8 | 0.24491527 |
| 105 | ZAK | 0.23344401 |
| 106 | MAP3K10 | 0.22886218 |
| 107 | HIPK2 | 0.22448814 |
| 108 | RPS6KB1 | 0.21695128 |
| 109 | ROCK1 | 0.20660564 |
| 110 | CSNK1G3 | 0.19611900 |
| 111 | RIPK1 | 0.19611398 |
| 112 | PRKACB | 0.19156514 |
| 113 | STK16 | 0.19039923 |
| 114 | IRAK3 | 0.18973763 |
| 115 | PRKD2 | 0.18456072 |
| 116 | MAP3K1 | 0.17491358 |
| 117 | SGK2 | 0.17002976 |
| 118 | NTRK2 | 0.16850986 |
| 119 | CDK5 | 0.16365626 |
| 120 | STK11 | 0.16363751 |
| 121 | MAPKAPK5 | 0.16351771 |
| 122 | CDK15 | 0.16134540 |
| 123 | ARAF | 0.15932631 |
| 124 | RPS6KA1 | 0.15781689 |
| 125 | SGK494 | 0.15007918 |
| 126 | SGK223 | 0.15007918 |
| 127 | CDK11A | 0.14026901 |
| 128 | CSNK1A1L | 0.13953593 |
| 129 | CASK | 0.12916291 |
| 130 | PDPK1 | 0.12351508 |
| 131 | MARK2 | 0.12256607 |
| 132 | CSNK1D | 0.11836684 |
| 133 | DAPK2 | 0.11800576 |
| 134 | CSNK1G2 | 0.11733092 |
| 135 | GSK3B | 0.11627976 |
| 136 | CDK6 | 0.11617779 |
| 137 | CSNK1G1 | 0.11350726 |
| 138 | CDK18 | 0.11245227 |
| 139 | PRKG1 | 0.10661069 |
| 140 | CDK14 | 0.09669474 |
| 141 | CDK4 | 0.09370821 |
| 142 | PRKD1 | 0.09310910 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.05508551 |
| 2 | Circadian rhythm_Homo sapiens_hsa04710 | 3.76823293 |
| 3 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.56892982 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.22537883 |
| 5 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.83657329 |
| 6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.81248191 |
| 7 | Insulin signaling pathway_Homo sapiens_hsa04910 | 2.45375297 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.34246684 |
| 9 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.30333272 |
| 10 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 2.19999688 |
| 11 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.02397907 |
| 12 | Insulin resistance_Homo sapiens_hsa04931 | 1.89266615 |
| 13 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.86906667 |
| 14 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.82233201 |
| 15 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.81930508 |
| 16 | Tight junction_Homo sapiens_hsa04530 | 1.73106320 |
| 17 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.70904537 |
| 18 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.69207168 |
| 19 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.57585943 |
| 20 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.57463085 |
| 21 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.54449702 |
| 22 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.51677204 |
| 23 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.49655843 |
| 24 | Viral myocarditis_Homo sapiens_hsa05416 | 1.43856661 |
| 25 | Sulfur relay system_Homo sapiens_hsa04122 | 1.41624322 |
| 26 | Carbon metabolism_Homo sapiens_hsa01200 | 1.40822408 |
| 27 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.39636776 |
| 28 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.38231132 |
| 29 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.32148943 |
| 30 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.26606676 |
| 31 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.25644513 |
| 32 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.24758152 |
| 33 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.24287261 |
| 34 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.23218327 |
| 35 | Huntingtons disease_Homo sapiens_hsa05016 | 1.21056542 |
| 36 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.18403777 |
| 37 | RNA degradation_Homo sapiens_hsa03018 | 1.17858365 |
| 38 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.14861941 |
| 39 | MAPK signaling pathway_Homo sapiens_hsa04010 | 1.14701289 |
| 40 | Galactose metabolism_Homo sapiens_hsa00052 | 1.14001244 |
| 41 | Focal adhesion_Homo sapiens_hsa04510 | 1.13677152 |
| 42 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.11028450 |
| 43 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.10440422 |
| 44 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.08730368 |
| 45 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.08307175 |
| 46 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.06994205 |
| 47 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.03367381 |
| 48 | Cell cycle_Homo sapiens_hsa04110 | 1.00356333 |
| 49 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.98583427 |
| 50 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.95194493 |
| 51 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.95091518 |
| 52 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.94822386 |
| 53 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.94747145 |
| 54 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.94420205 |
| 55 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.94079011 |
| 56 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.93814298 |
| 57 | Adherens junction_Homo sapiens_hsa04520 | 0.92320148 |
| 58 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.92310549 |
| 59 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.91830274 |
| 60 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.88572085 |
| 61 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.86754648 |
| 62 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.85686707 |
| 63 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.83111520 |
| 64 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.82906672 |
| 65 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.81677911 |
| 66 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.78378586 |
| 67 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.78343793 |
| 68 | Long-term depression_Homo sapiens_hsa04730 | 0.77648046 |
| 69 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.76864561 |
| 70 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.76767456 |
| 71 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.75236237 |
| 72 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.73986383 |
| 73 | Circadian entrainment_Homo sapiens_hsa04713 | 0.70205768 |
| 74 | Bladder cancer_Homo sapiens_hsa05219 | 0.66415433 |
| 75 | Renin secretion_Homo sapiens_hsa04924 | 0.66295352 |
| 76 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.66118970 |
| 77 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.65876474 |
| 78 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.65844914 |
| 79 | Glioma_Homo sapiens_hsa05214 | 0.64591603 |
| 80 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.63677401 |
| 81 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.62706964 |
| 82 | Basal transcription factors_Homo sapiens_hsa03022 | 0.62495008 |
| 83 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.61084870 |
| 84 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.58497399 |
| 85 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.56134607 |
| 86 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.56058050 |
| 87 | Lysine degradation_Homo sapiens_hsa00310 | 0.54334554 |
| 88 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.52894525 |
| 89 | Colorectal cancer_Homo sapiens_hsa05210 | 0.52332482 |
| 90 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.51470521 |
| 91 | Platelet activation_Homo sapiens_hsa04611 | 0.51440994 |
| 92 | Alzheimers disease_Homo sapiens_hsa05010 | 0.50784079 |
| 93 | Endometrial cancer_Homo sapiens_hsa05213 | 0.50386801 |
| 94 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.48828965 |
| 95 | Thyroid cancer_Homo sapiens_hsa05216 | 0.47510719 |
| 96 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.47295442 |
| 97 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.47274536 |
| 98 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.45595449 |
| 99 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.44889904 |
| 100 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.44853221 |
| 101 | RNA transport_Homo sapiens_hsa03013 | 0.44768998 |
| 102 | Insulin secretion_Homo sapiens_hsa04911 | 0.44109097 |
| 103 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.43693332 |
| 104 | Parkinsons disease_Homo sapiens_hsa05012 | 0.43434817 |
| 105 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.42523967 |
| 106 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.41970869 |
| 107 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.40757964 |
| 108 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.40754364 |
| 109 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.39279745 |
| 110 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.39083159 |
| 111 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.39059574 |
| 112 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.38992483 |
| 113 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38896575 |
| 114 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.38275044 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37856928 |
| 116 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.37030390 |
| 117 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.36799223 |
| 118 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.36795044 |
| 119 | Amoebiasis_Homo sapiens_hsa05146 | 0.35028258 |
| 120 | Peroxisome_Homo sapiens_hsa04146 | 0.34922091 |
| 121 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.33900323 |
| 122 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.33897576 |
| 123 | Melanoma_Homo sapiens_hsa05218 | 0.32468434 |
| 124 | GABAergic synapse_Homo sapiens_hsa04727 | 0.31921312 |
| 125 | Salivary secretion_Homo sapiens_hsa04970 | 0.31688277 |
| 126 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.30752973 |
| 127 | HTLV-I infection_Homo sapiens_hsa05166 | 0.28733923 |
| 128 | Melanogenesis_Homo sapiens_hsa04916 | 0.27135704 |
| 129 | Long-term potentiation_Homo sapiens_hsa04720 | 0.26985069 |
| 130 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.26981027 |
| 131 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.26811316 |
| 132 | Metabolic pathways_Homo sapiens_hsa01100 | 0.26674788 |
| 133 | Olfactory transduction_Homo sapiens_hsa04740 | 0.26589638 |
| 134 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.26526958 |
| 135 | Purine metabolism_Homo sapiens_hsa00230 | 0.26515004 |
| 136 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.26361682 |
| 137 | Phototransduction_Homo sapiens_hsa04744 | 0.23141174 |
| 138 | Axon guidance_Homo sapiens_hsa04360 | 0.22565768 |
| 139 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.21202402 |

